We are live on ! Find out more
ZVSA

ZyVersa Therapeutics

Delisted

ZVSA was delisted on the 16th of July, 2025.

4 hedge funds and large institutions have $38.7K invested in ZyVersa Therapeutics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.08% more ownership

Funds ownership: 0.15%1.23% (+1.1%)

43% less funds holding

Funds holding: 74 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

54% less capital invested

Capital invested by funds: $84.9K → $38.7K (-$46.1K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
-3
Holders Change %
-42.86%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
1
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
ADAR1 Capital Management
Texas
$36.1K +$51.5K +9,598 New
TRCT
2
Tower Research Capital (TRC)
New York
$2.63K -$831 -155 -18%
Bank of America
3
Bank of America
North Carolina
$26 +$38 +7 New
JP Morgan Chase
4
JP Morgan Chase
New York
$4 +$5 +1 New
TSS
5
Two Sigma Securities
New York
-$23.4K -3,121 Closed
CSS
6
Cubist Systematic Strategies
Connecticut
-$22K -2,937 Closed
UBS Group
7
UBS Group
Switzerland
-$14.9K -1,991 Closed
HF
8
HRT Financial
New York
-$9K -1,318 Closed
Jane Street
9
Jane Street
New York
-$9.09K -1,212 Closed
Wells Fargo
10
Wells Fargo
California
-$9 -1 Closed